White paperThe Enterprise Framework for Compliant, Scalable AI
Download now
AI deploymentContinuous complianceData

GxP System Validation and Monitoring for Half the Cost

Learn how an emerging therapeutics company saves more than $400k annually and maintains SaaS systems for half that cost.

Client profile: Newly commercialized emerging therapeutics company managing eight GxP-compliant SaaS systems under stringent regulatory requirements.

GxP System Validation and Monitoring for Half the Cost graphic

Executive takeaway

By partnering with USDM, an emerging therapeutics company reduced GxP SaaS validation and maintenance costs by half, saving more than $400,000 annually and cutting four positions while two employees now run work that once required a full team.

Annual Savings

$400K+

Reduced headcount by four positions, saving over $400,000 annually while maintaining SaaS systems for half the previous cost.

Manual Workload Cut

80%+

USDM Cloud Assurance automated compliance validation drastically reduced manual workloads by more than 80% across eight GxP systems.

Report Accuracy

99.9%

Quarterly DocuSign reports delivered with 99.9% accuracy alongside comprehensive Veeva configuration reviews.

Before USDM

  • A full team consumed by labor-intensive validation and compliance maintenance across eight GxP systems
  • 35 to 40 change controls processed every quarter, increasing risk of inefficiencies and non-compliance
  • Rising exposure to non-compliance as SaaS applications and release velocity intensified

After USDM

  • Two employees handle the validation work that previously required a full team
  • Manual workloads cut by more than 80% through automated compliance validation
  • Over $400,000 saved annually with four positions eliminated and audit readiness strengthened

How an emerging therapeutics company saved more than $400K annually and maintained its SaaS systems for half the cost

Life sciences companies that perform their own Software-as-a-Service (SaaS) validation and ongoing maintenance may not get the return on investment (ROI) they anticipated—particularly when more SaaS applications are added to the tech stack and the complexity and velocity of releases intensify.

The Challenge

An emerging therapeutics company, newly commercialized, recognized early the critical importance of GxP-compliant SaaS systems to ensure product quality and meet stringent regulatory requirements. Managing eight GxP systems, however, quickly became a challenge. Quarterly, system and business owners faced the arduous task of processing 35 to 40 change controls, increasing the risk of inefficiencies and non-compliance.

  • Complex System Management: High volume of change controls and system updates across eight GxP systems.
  • Resource Drain: Labor-intensive validation and compliance maintenance required extensive staffing.
  • Compliance Risk: Potential exposure to non-compliance amid growing complexity and rapid SaaS release cycles, raising the stakes for 21 CFR Part 11 and data integrity requirements.

USDM's Approach

The therapeutics company partnered with USDM Life Sciences to leverage its comprehensive suite of capabilities, modernizing validation with a risk-based, Computer Software Assurance (CSA) mindset.

Trust & Compliance

  • USDM Cloud Assurance: Delivered automated compliance validation, drastically reducing manual workloads by more than 80%.
  • DocuSign + Veeva Integration: Quarterly DocuSign reports with 99.9% accuracy and comprehensive Veeva configuration reviews simplified compliance efforts.

Data Insights & Control

  • Real-time GxP system monitoring through the Cloud Assurance Digital Experience (Dx) Portal, enabling proactive management of system statuses.

Content Management

  • Validated Box for GxP and non-GxP document storage, wrote SOPs, and provided end-user training, ensuring seamless and compliant document workflows.

Workflow Automation

  • Streamlined validation workflows, enabling two employees to handle work that previously required a full team.

Results and Business Outcomes

  • Cost Savings: Reduced headcount by four positions, saving over $400,000 annually—maintaining SaaS systems for half the previous cost.
  • Operational Efficiency: Freed up highly skilled employees to focus on the company's core mission of developing therapeutics, rather than being consumed by validation tasks.
  • Scalability: Simplified SaaS system management allows the company to confidently scale its technology stack without risking compliance.
  • Proven Accuracy: Delivered reports and validation with near-perfect reliability, reducing compliance risks and enhancing audit readiness.

By harnessing USDM's cutting-edge capabilities, the therapeutics company now operates with greater agility, reduced risk, and a laser focus on its mission of improving patient outcomes. USDM's innovative approach to GxP compliance and SaaS system optimization delivers measurable results, ensuring technology supports—not hinders—innovation. Talk to USDM about validating and monitoring your GxP systems for half the cost.

Continuous Compliance

Validate and monitor your GxP SaaS systems for half the cost

See how USDM Cloud Assurance automates compliance validation, streamlines change control, and keeps your GxP cloud applications audit-ready as your tech stack scales.

Explore USDM Cloud Assurance

Go deeper

Related guidance

Blogs, webinars, and white papers on the capabilities behind this outcome.

Blog

Compliant Data Migration Solutions

Compliant data migration in life sciences is rarely a simple copy — it demands mapping, transformation, and validation. Learn how a GxP-ready migration plan protects data integrity and minimizes downtime.

Read
Webinar

Work Faster and Smarter in Biotech Quality Management

Watch this on-demand webinar to see how Box, ComplianceQuest, and USDM Life Sciences bundle quality management so biotechs cut stand-up times, control costs, and run a best-of-breed compliance stack.

Read
Blog

Seamless Compliance and Cost Savings with USDM’s Veeva-DocuSign Integration Accelerator

USDM’s Veeva-DocuSign Integration Accelerator lets life sciences teams capture compliant eSignatures from external signers without extra Veeva licenses—cutting cost and complexity while preserving 21 CFR Part 11 audit readiness.

Read
Blog

6 Considerations for Reducing Your IT Cost of Ownership

A practical guide to the six cost drivers life sciences IT leaders should weigh—acquisition, operations, maintenance, compliance, upgrades, and replacement—to lower total cost of ownership without sacrificing GxP compliance.

Read
Blog

Are You Ready for the Veeva 21R3 Release?

The Veeva 21R3 release brings Email to Vault, Vault Mobile, and Google Drive integration. Learn how USDM helps life sciences teams adopt these features while keeping Vault validated and continuously compliant.

Read
Blog

Information System (IS) Compliance Health Check

Assess your cloud readiness, IS compliance maturity, and process efficiency with USDM's Information System (IS) Compliance Health Check — a people, process, and technology evaluation that builds a clear roadmap to compliance maturity.

Read

Start here

Put AI to work in life sciences — with the right guardrails underneath.

Start with a structured AI Readiness Assessment: fixed-fee, executive-ready, and built to surface the highest-value workflows first.

Start here

Talk to USDM

Tell us what workflow or outcome you want to improve and we'll map the right AI, governance, and delivery path.

By submitting this form, you agree to USDM’s Privacy Policy and consent to receive communications from USDM. You can unsubscribe at any time using the link in our emails.